• On sale!
  • Out-of-Stock
search

OCTILIA ALL INF * COLL10FL 0.5ML

  • IBSA Farmaceutici Italia S.r.l.
  • 043903018

Octilia Allergy and Inflammation is a drug based on the active ingredient tetrizoline + pheniramine, belonging to the category of Decongestants and specifically Sympathomimetics used as decongestants. Octilia Allergy and Inflammation can be prescribed with OTC Recipe - self-medication. In allergic and inflammatory states of the conjunctiva accompanied by photophobia, lacrimation, foreign body sensation, pain.

info_outline View product sheet
Final Price €8.50

Volume discounts

Quantity Unit discount You Save
2 10% €1.70
5 15% €6.38
10 25% €21.25
error Out-of-Stock

Notify me when available

  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Antihistamine eye drops Others products at unbeatable price

IBSA Farmaceutici Italia S.r.l.

Discover all products

OCTILIA ALL INF * COLL10FL 0.5ML

Therapeutic indications

In allergic and inflammatory states of the conjunctiva accompanied by photophobia, lacrimation, foreign body sensation, pain.

Dosage and method of use

Instill 1-2 drops in the affected eye 2-3 times a day. Do not exceed the recommended dose. Strictly adhere to the recommended doses. A higher dosage of the product even if taken topically and for a short period of time can give rise to serious systemic effects.

Contraindications

Hypersensitivity towards the components of the product or other strictly correlated substances from a chemical point of view; in particular towards xylometazoline, oximetazoline, tetrizoline. Narrow / closed angle glaucoma or other serious eye disease. Contraindicated in children under the age of twelve. Generally contraindicated during pregnancy and lactation (see section 4.6). Contraindicated in the simultaneous treatment with monoamine oxidase inhibitors (tranylcypromine, phenelzine, pargiline) (see par. 4.5).

Side effects

The use of the product can sometimes cause pupillary dilation, systemic effects from absorption (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. In children, if accidentally ingested, the preparation can cause deep sleep and hypotonia. Hypersensitivity phenomena may rarely occur. In this case, treatment must be interrupted and appropriate therapy instituted.Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows for continuous monitoring of the benefit / risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the Italian Medicines Agency, Website: (https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse).

Special warnings

The product, although presenting a very low systemic absorption, must be used with caution in subjects suffering from hypertension, hyperthyroidism, heart disorders, and hyperglycemia (diabetes). In case of persistence or worsening of symptoms after a short period of treatment, invite the patient to consult the doctor. In any case, the product should not be used for more than 4 consecutive days, unless otherwise prescribed, given the possibility that unwanted effects may otherwise occur. The product, if accidentally ingested or if used for long periods in excessive doses, can cause toxic phenomena. Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. The use, especially if prolonged, of topical products can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and institute a suitable therapy.Important information about some of the ingredients:This medicine, in the 10 ml bottle pack, contains 0.012 mg of benzalkonium chloride for the maximum recommended daily dose of 6 drops (0.24 ml) equivalent to 0.05 mg / ml. Benzalkonium chloride as a preservative can be absorbed by soft contact lenses and can lead to a change in their color, can give rise to sensitization reactions and should not be applied while wearing contact lenses (in the case of contact lens wearers, wear the same only 15 minutes after using the product). Benzalkonium chloride can also cause eye irritation especially if you have dry eye or corneal disease (the topmost transparent layer of the eye). In these cases it is possible to use the single-dose container that does not contain preservatives.

Pregnancy and breastfeeding

There are no or limited data from the use of pheniramine maleate and tetrizoline hydrochloride in pregnant women. As a precaution, it is preferable during pregnancy and lactation to use OCTILIA ALLERGY AND INFLAMMATION only in case of real need, under the direct supervision of the doctor.

Expiry and retention

Do not store above 25 ° C.

Interactions with other drugs

OCTILIA ALLERGY AND INFLAMMATION should not be used concomitantly with the intake of monoamine oxidase inhibitor drugs, as this can lead to the onset of severe hypertensive crisis.

Overdose

The product, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena. Accidental ingestion of the drug, especially in children, can cause central nervous system depression: marked sedation (severe drowsiness), coma. If this happens, use gastric lavage and general supportive measures.

Active principles

100 ml of solution contain: Active ingredients: Pheniramine maleate 0.30 g; Tetrizoline hydrochloride 0.05 g. Excipient with known effect (10 ml bottle): benzalkonium chloride. par. 6.1

Excipients

Multidose bottle : Boric acid; Borax; Benzalkonium Chloride; Water for injections. Single-dose container : Boric acid; Borax; Water for injections.

043903018

Data sheet

Packaging
3 mg / ml + 0.5 mg / ml eye drops, solution 10 single-dose containers of 0.5 ml
Product Type
HUMAN DRUG
ATC code
S01GA52
ATC description
Tetrizoline, associations
Therapeutic Group
Decongestants
Active principle
tetrizoline + pheniramine
Class
C.
Pharmaceutical form
eye drops
Type of Administration
ophthalmic
Container
pipette / single-dose containers
Quantity
10 pipette / single-dose container
Capacity
0.5 milliliters
Quantity of the Active Ingredient
30MG (pheniramine) + 5MG (tetrizoline)
Recipe required
OTC - self-medication medicine
chat Comments (0)
Fast Order